In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1731 News Items found
MSK thoracic surgeon Prasad Adusumilli
New Design Could Make CAR T Cells a More Effective Immunotherapy for Solid Tumors

Learn how researchers engineered CAR T cells to work better by using a mutation in a gene called c-KIT that drives cancer cell growth.
Feature
Gloved hands holding a pipette.
Your Gut Microbiome: How To Improve It, Its Effects on the Immune System, and More

This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
A breast cancer cell containing micronuclei
MSK-Led Research Finds Unexpected Link Between Chromosomal Instability and Epigenetic Alterations

MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.
Kieran Healy is seen smiling outdoors next to his bike, after successful treatment for lymphoma at Memorial Sloan Kettering.
How MSK’s Rapid Diagnosis Got Kieran Treated Quickly for Lymphoma

Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.
Feature
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting

MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
See Dr. Deb Schrag standing in a hallway. She led a clinical trial involving rectal cancer at Memorial Sloan Kettering.
Rectal Cancer Treatment Without Radiation: A New Option

Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder and sexual function.
In the Lab
Dr. Piro Lito
Potential Drug Shows Promise Targeting a Range of KRAS-Driven Cancers in the Lab

MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.
Feature
Back row from left to right: Zongmin Wang, Miguel Miranda-Román, Stella Paffenholz, Anton Dobrin, Bradley Benjamin, Caroline Gleason, Paige Arnold, and Mollie Chipman. Front row, from left to right: Yasemin Kaygusuz, Maria Sirenko, Buren Li, Tingxu Chen, Nayan Jain, Florisela Herrejon Chavez, and Adele Whaley.
MSK’s 2023 Commencement Celebrates Largest Class in History and Honors Award Winners

MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.
a composite showing a black and white, historical photo of a woman at the microscope on the left, and a modern version of a similar picture on the right
MSK’s Sloan Kettering Institute Celebrates 75 Years of Discovery

Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
An MSK scientist pipettes in the lab
MSK Research Highlights, May 18, 2023

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.